Medical News

RSS

Study: Two-thirds of asthmatics also have allergy

Asthma is becoming an epidemic in the United States. The number of Americans diagnosed with asthma grows annually, with 26 million currently affected. And according to a new study, nearly two-thirds or more of all asthmatics also have an allergy, which can make this spring season particularly bothersome.

2 Apr 2013

New support program for single fathers

Men who have dependent children and whose spouses or partners died from cancer are an overlooked population. These fathers face unique challenges not addressed by traditional grief support groups that often attract an older, female population.

2 Apr 2013

Risk prediction tools that estimate future risk of stroke and heart disease may also predict memory loss

Risk prediction tools that estimate future risk of heart disease and stroke may be more useful predictors of future decline in cognitive abilities, or memory and thinking, than a dementia risk score, according to a new study published in the April 2, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Apr 2013

NanoVelcro chip device can help identify cancerous cells for treating prostate cancer

A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.

2 Apr 2013

Supporters of Medicaid expansion fight to be heard in some statehouses

Mississippi House Democrats blocked passage of the state's Medicaid budget Sunday to force a vote on expanding the program, while supporters and critics do battle in Missouri, Montana and Arkansas.

2 Apr 2013

Researchers identify link between immune response and blood clotting

Rice University researchers have found an unexpected link between a protein that triggers the formation of blood clots and other proteins that are essential for the body's immune system.

2 Apr 2013

V/Q imaging can detect early stages of COPD

In vivo ventilation/perfusion (V/Q) imaging can detect early changes to the lung caused by cigarette smoke exposure and provides a noninvasive method for studying lung dysfunction in preclinical models, according to research published in the April issue of The Journal of Nuclear Medicine.

2 Apr 2013

HAP caused by exposure to biomass fuels increases mortality risk

Almost four million people die each year from household air pollution (HAP) caused by exposure to the combustion of biomass fuels (wood, charcoal, crop residues, and dung), kerosene, or coal.

2 Apr 2013

Microbiology testing services now offered by Ceram

Ceram, the international materials testing and development company, has announced that it is now offering microbiology testing services for the healthcare industries, thanks to a partnership with a leading UK microbiological testing lab.

2 Apr 2013

New born neurons as a therapeutic strategy: an interview with Mi-Hyeon Jang, Mayo Clinic in Rochester, Minnesota

There are two regions in the brain that continue to produce new neurons well into adulthood. One of these regions is the hippocampus and as we converse this region is actively involved in memory formation, mood regulation and cognition.

2 Apr 2013

Revance Therapeutics raises $33M in Series E financing

Revance Therapeutics, Inc., a privately held specialty biopharmaceutical company developing novel botulinum toxin products for use in aesthetic and therapeutic indications, today announced that it has raised $33 million of its Series E growth financing.

2 Apr 2013

NewLink Genetics starts Phase 2 clinical study of indoximod in patients with metastatic breast cancer

NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.

2 Apr 2013

First Edition: April 2, 2013

Kaiser Health News consumer columnist Michelle Andrews answers readers' questions about the new marketplaces where consumers can buy 2014 health policies as part of the federal health law. (Andrews, 4/2).

2 Apr 2013

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.

2 Apr 2013

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Inovio Pharmaceuticals, Inc. today announced the release of preliminary clinical trial results by its collaborator ChronTech AS of their open label phase II clinical study of ChronVac-C, ChronTech's vaccine to treat hepatitis C virus infection.

2 Apr 2013

Eight new grant recipients to receive funding to conduct health impact assessments

The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable Trusts, today announced eight new grant recipients that will receive funding to conduct health impact assessments, or HIAs.

2 Apr 2013

ShopSmart magazine's April issue features answers to common questions about Vitamin D

Vitamin D has been touted as the answer to all kinds of health problems, but many of these claims are overblown. The April 2013 issue of ShopSmart magazine, from Consumer Reports, features answers to some of the most common questions about Vitamin D and names the best from its tests of 32 products.

2 Apr 2013

Post-2015 framework will fail in tackling inequality without inclusion of disability

"The communiqué released at the end of the U.N. high-level panel meeting on the post-2015 development agenda failed to mention disability, repeating in Bali the same omission notable in last month's official communiqué from the Monrovia meeting," Dominic Haslam, director of policy and strategic program support at Sightsavers, and Virginia Kamowa, global advocacy coordinator for the organization, write in The Guardian's "Poverty Matters" blog.

2 Apr 2013

Phase II study shows effectiveness of Axelar's AXL-003 in treating patients with NSCLC

Axelar AB, part of the Karolinska Development AB portfolio, announced today that preliminary interim results of its Phase II study AXL-003, indicates that AXL1717 is effective in treating patients with non-small cell lung cancer.

2 Apr 2013

GZS releases WebTracker-Hemophilia EHR patient registry system

GZS, Inc., a leader in developing disease-specific and condition-specific Electronic Medical Records/Electronic Health Records and patient registry software solutions, has announced the worldwide release of the WebTracker-Hemophilia EHR patient registry solution used under the new brand name HemaGlobal.

2 Apr 2013

Medical News

Study: Two-thirds of asthmatics also have allergy

New support program for single fathers

Risk prediction tools that estimate future risk of stroke and heart disease may also predict memory loss

NanoVelcro chip device can help identify cancerous cells for treating prostate cancer

Supporters of Medicaid expansion fight to be heard in some statehouses

Researchers identify link between immune response and blood clotting

V/Q imaging can detect early stages of COPD

HAP caused by exposure to biomass fuels increases mortality risk

Microbiology testing services now offered by Ceram

New born neurons as a therapeutic strategy: an interview with Mi-Hyeon Jang, Mayo Clinic in Rochester, Minnesota

Revance Therapeutics raises $33M in Series E financing

NewLink Genetics starts Phase 2 clinical study of indoximod in patients with metastatic breast cancer

First Edition: April 2, 2013

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Eight new grant recipients to receive funding to conduct health impact assessments

ShopSmart magazine's April issue features answers to common questions about Vitamin D

Post-2015 framework will fail in tackling inequality without inclusion of disability

Phase II study shows effectiveness of Axelar's AXL-003 in treating patients with NSCLC

GZS releases WebTracker-Hemophilia EHR patient registry system

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News